ZenaTech, Inc. (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA), a technology solutions provider specializing in AI-powered drones, Drone as a Service (DaaS), enterprise software and quantum computing, announced that its ZenaDrone subsidiary has signed a memorandum of understanding (MOU) with Rattler Medical Inc. to develop and manufacture a drone-based battlefield blood delivery system. The proposed system will combine ZenaDrone's cargo drone capabilities with Rattler Medical's temperature-controlled blood transport containers to deliver blood to military medical personnel more quickly while reducing reliance on ground transportation in combat environments. Under the agreement, the companies plan to develop and test a flying prototype within two to three months, evaluating delivery methods that include aerial release and landing-based deployment. ZenaDrone is targeting a demonstration at a U.S. military facility in summer 2027.
The initiative expands ZenaTech's defense portfolio into battlefield medical logistics, with the companies seeking to improve blood resupply capabilities and reduce risks associated with transporting medical supplies through contested areas. This matters because timely blood delivery is critical for saving lives on the battlefield, and using drones could bypass ground convoys that are vulnerable to ambushes and IEDs, potentially increasing survival rates for wounded soldiers. To view the full press release, visit https://ibn.fm/xSVke.
ZenaTech, through its subsidiaries, specializes in AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global DaaS business, and an enterprise SaaS division. The company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as ISR, cargo, and counter-UAS for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&D initiatives. To learn more about ZENA, visit https://www.zenatech.com/.
The announcement was distributed through DefenseWireNews (DWN), a specialized communications platform focused on defense contractors, aerospace firms, cybersecurity leaders, advanced manufacturing innovators, and other mission-critical companies. DWN is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions.
For investors, the MOU signals ZenaTech's continued push into defense-related drone applications, potentially opening new revenue streams in military medical logistics. The collaboration with Rattler Medical, a specialist in temperature-controlled blood transport, could position ZenaDrone as a key player in autonomous medical resupply, a niche with growing demand as militaries seek to reduce logistical risks. The planned prototype and demonstration timeline provide tangible milestones to watch. However, as with any early-stage development, execution risks remain, and the financial terms of the MOU were not disclosed. For full terms of use and disclaimers applicable to all content provided by DWN, visit https://www.DefenseWireNews.com/Disclaimer.
